🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Lymphoblastic Leukemia in Children

CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia NCT07328503Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: CD22 CAR-transduced T cells, Cyclophosphamide, Fludarabine Newly-diagnosed Pediatric Ph-positive B-ALL Protocol NCT07152041Phase 324 sites📍 Hefei📍 Chongqing📍 Fuzhou Institute of Hematology & Blood Diseases Hospital, China · Tests: olverembatinib Cord Blood Transplantation in Children and Young Adults With Blood Cancer NCT07566377Phase 21 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: Cord Blood Units, Total Body Irradiation, Cyclophosphamide, Fludarabine, Clofarabine Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children NCT06099366Phase 213 sites📍 Seoul📍 Seoul📍 Yangsan Hee Young Ju · Tests: induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal Methotrexate, Consolidation: Vinc… Venetoclax Basket Trial for High Risk Hematologic Malignancies NCT05292664Phase 15 sites📍 San Francisco📍 Aurora📍 Atlanta Andrew E. Place, MD · Tests: Venetoclax, Azacitidine, Cytarabine, Methotrexate, Hydrocortisone Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia NCT05512169n/a2 sites📍 New Delhi📍 Puducherry University of Geneva, Switzerland CD-19 CAR-T Cell for Pediatric ALL or Lymphoma NCT06866873NA1 site📍 Hong Kong Hong Kong Children's Hospital · Tests: CAR-T Digital Health Promotion for Children With Congenital Heart Disease and Their Guardians NCT06626672NA1 site📍 München Deutsches Herzzentrum Muenchen · Tests: Digital Health Intervention Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol NCT06764238Phase 2, Phase 327 sites📍 Hefei📍 Hefei📍 Fuzhou Institute of Hematology & Blood Diseases Hospital, China · Tests: Blinatumomab (Group A), Venetoclax (nonRand Group), Blinatumomab (Group B) Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia NCT04209244NA4 sites📍 Aalborg📍 Aarhus📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: Eskimo-3 Pure Fish Oil, Rapeseed Oil Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL NCT05495035Phase 14 sites📍 Hefei📍 Jinan📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Olverembatinib, APG-2575, Dexamethasone Artistic and Movement Activities to Reduce Anxiety in Children With Acute Lymphoblastic Leukemia. NCT07878065Phase 31 site📍 Cairo Children's Cancer Hospital Egypt 57357 · Tests: Art and physical activity program. CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia NCT05043571Phase 11 site📍 Singapore National University Hospital, Singapore · Tests: CAR T-cell therapy Study of the Medullary Microenvironment in Acute Childhood Leukemia NCT05792007NA3 sites📍 Tours📍 Tours📍 Tours University Hospital, Tours · Tests: Biological sampling in patients, Biological sampling in control patients CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies NCT05442515Phase 1, Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: CD19/CD22-CAR-transduced T cells, cyclophosphamide, fludarabine A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph... NCT05621291NA8 sites📍 Los Angeles📍 Washington D.C.📍 Atlanta National Cancer Institute (NCI) · Tests: NGS testing The Effect of Mandala on Anxiety and Fear Levels in Children With Leukemia Before Intrathecal Chemotherapy Treatment NCT07203742NA1 site📍 Izmir Ege University · Tests: mandala painting Using Mobile Technology-assisted Outpatient Maintenance Therapy Pediatric ALL NCT07278882NA1 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Health monitoring & reminders for a mobile-phone portal for scheduling a telemedicine clinic visit and receive peri… Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence NCT05310591Phase 1, Phase 213 sites📍 Bordeaux📍 Lille📍 Lyon Assistance Publique - Hôpitaux de Paris · Tests: Decreasing starting times for beginning nivolumab (Time to Event Continual Reassessment Method (TITE-CRM) ), Nivolumab … Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma NCT06289673Phase 45 sites📍 San Diego📍 Baton Rouge📍 Charlotte St. Jude Children's Research Hospital · Tests: Dexamethasone, Vincristine, Daunorubicin, Intrathecal triple therapy (methotrexate + hydrocortisone + cytarabine), Meth… Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ... NCT02390752Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: TURALIO(R) Ph+ ALL in Chinese Children: Diagnosis, Treatment, and Survival NCT07813208n/a1 site📍 Hangzhou The Children's Hospital of Zhejiang University School of Me… CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children. NCT06752785Phase 11 site📍 Guangzhou Guangzhou Women and Children's Medical Center · Tests: CAR-T Therapy Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children NCT06529575n/a3 sites📍 New York📍 Philadelphia📍 Houston University of Pennsylvania Phase I Clinical Trial of CART Cell Therapy for Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults NCT06709469Phase 11 site📍 Madrid Instituto de Investigación Hospital Universitario La Paz · Tests: Autologous CD19/CD22 CAR T cells, Allogeneic CART-NKG2D cells Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia NCT06756022n/a1 site📍 Hefei Anhui Provincial Children's Hospital · Tests: Dolasetron mesylate injection The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study NCT04726241Phase 1, Phase 2184 sites📍 Birmingham📍 Mobile📍 Anchorage PedAL BCU, LLC · Tests: Biospecimen Collection HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies NCT05658640Phase 1, Phase 236 sites📍 Vienna📍 Ghent📍 Copenhagen Princess Maxima Center for Pediatric Oncology · Tests: Trametinib, Dexamethasone, Cyclophosphamide, Cytarabine, Intrathecal chemotherapy Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL) NCT05681260Phase 32 sites📍 Shanghai📍 Chengdu Children's Cancer Group, China · Tests: Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine… Newly-diagnosed Pediatric T-cell ALL Protocol NCT06855810Phase 2, Phase 327 sites📍 Hefei📍 Hefei📍 Chongqing Institute of Hematology & Blood Diseases Hospital, China · Tests: Venetoclax, Dasatinib, homoharringtonine
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy